Home

Balaxi Pharmaceuticals Ltd PE Ratio

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

PE

11.9

Last updated on: Feb 22, 2025

Key Highlights

  • The P/E Ratio of Balaxi Pharmaceuticals Ltd is 11.9 as of 22 Feb 12:14 PM .
  • The P/E Ratio of Balaxi Pharmaceuticals Ltd changed from 12.1 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 years.
  • The Latest Trading Price of Balaxi Pharmaceuticals Ltd is ₹ 56.68 as of 21 Feb 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 21.0 to 40.0 in 5 years. This represents a CAGR of 13.75%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.3. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 36.9 in 2024.

Historical P/E Ratio of Balaxi Pharmaceuticals Ltd

No data available

Company Fundamentals for Balaxi Pharmaceuticals Ltd

Image

Balaxi Pharmaceuticals Ltd

NSE: BALAXI

Share Price

₹ 56.68

0.91 (1.63%)

stock direction

Last updated on: Feb 21, 2025

Market Price of Balaxi Pharmaceuticals Ltd

1M

1Y

3Y

5Y

Monitoring Balaxi Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
21 Feb 202556.68
20 Feb 202555.77
19 Feb 202553.94
18 Feb 202552.18
17 Feb 202555.87
14 Feb 202560.16
13 Feb 202560.86
12 Feb 202566.08
11 Feb 202565.11
10 Feb 202568

SWOT Analysis Of Balaxi Pharmaceuticals Ltd

Strength

4

che

Weakness

1

che

Opportunity

0

che

Threats

1

che

BlinkX Score for Balaxi Pharmaceuticals Ltd

Asset Value vs Market Value of Balaxi Pharmaceuticals Ltd

Market Value

0

Asset Value

0

* All values are in ₹ crores

Competitive Comparison of P/E Ratio

Company
leftMarket Capright
Balaxi Pharmaceuticals Ltd312.92
Sun Pharmaceuticals Industries Ltd394223
Divis Laboratories Ltd152610
Cipla Ltd119067
Torrent Pharmaceuticals Ltd102739
Dr Reddys Laboratories Ltd96124

PE Ratio of Balaxi Pharmaceuticals Ltd Explained

312.92

Market cap

27

Earnings

11.9X

PE Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Balaxi Pharmaceuticals Ltd

No data available

* All values are in crore

Historical Revenue, EBITDA and Net Profit of Balaxi Pharmaceuticals Ltd

Revenue

EBITDA

Net Profit

No data available

* All values are in crore

Historical Dividend Payout of Balaxi Pharmaceuticals Ltd

No data available

* All values are in %

About Balaxi Pharmaceuticals Ltd

  • Balaxi Ventures Limited was formerly incorporated in the name of 'The Anandam Rubber Company Limited' on September 28, 1942.
  • The Company changed its name from 'The Anandam Rubber Company Limited' to 'Balaxi Ventures Limited' on August 08, 2017.
  • The Company incorporated with a basic objective of running rubber and tea plantations and owns several plantations across South India. In year 1989 the company sold its entire plantations to meet the emerging business needs and started concentrating in Investments and trading.
  • The company previously was a investment company, but the company during the financial year 2018-19 has commenced the business of International Wholesale Trading of Pharmaceuticals, Builders Hardware and FMCG Products On 15 March 2017, Balaxi Overseas Private Limited (BOPL) entered into a Share Purchase Agreement (SPA) with the erstwhile promoters of Company (i.

Balaxi Pharmaceuticals Ltd News Hub

Balaxi Pharmaceuticals reports consolidated net profit of Rs 6.48 crore in the June 2024 quarter

Net profit of Balaxi Pharmaceuticals reported to Rs 6.48 crore in the quarter ended June 2024 as aga

Read more

02 Aug 24

Balaxi Pharmaceuticals to conduct AGM

Balaxi Pharmaceuticals announced that the 81st Annual General Meeting(AGM) of the company will be he

Read more

01 Aug 24

Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September

Read more

05 Nov 24

Balaxi Pharmaceuticals announces board meeting date

Balaxi Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 5 November 20

Read more

30 Oct 24

Product Composition by Percentage (Revenue)

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Balaxi Pharmaceuticals Ltd

What is the current PE Ratio of Balaxi Pharmaceuticals Ltd?

The Current PE Ratio of Balaxi Pharmaceuticals Ltd is 11.88 as on 22 Feb 2025.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 22 Feb 2025.

What was the PE Ratio of Balaxi Pharmaceuticals Ltd last year?

The PE Ratio of Balaxi Pharmaceuticals Ltd was 11.75 last year, now the PE ratio is 11.88, showing a year-on-year growth of 1.1%.

What does the PE Ratio of Balaxi Pharmaceuticals Ltd indicate about its stock?

The PE Ratio of Balaxi Pharmaceuticals Ltd is 11.88. This ratio indicates that investors are willing to pay 11.88 times the earnings per share for each share of Balaxi Pharmaceuticals Ltd.

What is the PE Ratio Growth of Balaxi Pharmaceuticals Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Balaxi Pharmaceuticals Ltd grew by 1.1% whereas, the EPS ratio grew by 15.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions